Experimental Drug Benefits Patients with Advanced Prostate Cancer – NCI Cancer Bulletin
by Admin on 09/03/10 at 6:46 pm
">Daily Mail Experimental Drug Benefits Patients with Advanced Prostate Cancer NCI Cancer Bulletin The experimental drug cabazitaxel has improved the survival of some patients with advanced prostate cancer compared with those who received standard chemotherapy, according to results from a randomized phase III clinical trial presented last week at … Doctor's Specialty Often Steers Prostate Cancer Care BusinessWeek Dietary Fat and Prostate Cancer Risk Renal and Urology News Type of physician associated with prostate cancer treatment HemOncToday Telegraph.co.uk